Professional biotech news today? BioTech Health X brings you the newest professional biotech news including breaking news on the latest biotechnology research, emerging companies, biotech acquisitions, funding deals and other industry analysis. Our coverage not only includes study news and site updates from researchers but also financial analysis of the high and low daily market including several of the last market moves, first opening market updates, top share tips and more. Get everything you need delivered straight to your Inbox with our newsletter based on the science research and stories you want to read and follow from our team. Sign up for free today!
The product is a medical device used with the aim of facilitating regeneration and reconstructing functions of peripheral nerves severed or lost due to external injury. The device is a tube made of polyglycolic acid filled with sponge-shaped collagen, which enables the creation of an environment to induce nerve growth and reconstruct the severed section. The sponge-like structure of collagen has been confirmed as effective in multiplying nerve cells. The nerve conduit products made of synthesized materials that are available on the overseas market have reportedly caused some instances of triggering inflammatory reactions when the materials have decomposed inside the body*4. However, such events were not found with Nerbridge TM in a systematic literature search Toyobo has been making for the past several years in Japan. Using Nerbridge TM makes it unnecessary to harvest healthy peripheral nerves for autografting, reducing the patient’s burden and shortening the time needed for surgical treatment.
Miller shared that CureDuchenne provided early funding to a large percentage of companies in the DMD space that are now in the clinical trial stage. Our vision is our name: to cure Duchenne, she said. Our goal is to uncover, fund and de-risk early science. By finding the technology that’s most likely to work for Duchenne, the company is filling the therapeutic pipeline. Miller makes a point to sit in on the Department of Defense’s Congressionally Directed Medical Research Programs, and stated that CureDuchenne is the largest funder of DMD research outside of the federal government. She described the softer side of the company, outlining its commitment to providing community support. One thing that is really important to us is providing hope to the families. We do that by highlighting and celebrating things that our young men with Duchenne can do. We focus on their accomplishments and how they’re continually raising the bar in terms of their achievements.
Get up to date information as researchers study the genetic developments, disease, cancer, DNA, proteins, immune systems, and simultaneously discussing the current virus COVID 19 (SARS COV 2) as international researchers study, target and search for what may be produced and needed for useful new breakthroughs. Topics range from companies focused on cardiovascular disease to gene therapy, regenerative biotechnology, pathogens, tissue regeneration and more. Discover additional info at biotechhealthx.com.
There are several factors that are helping to drive the growth of the global passive prosthetics market. One of the biggest driving factors in the growing number of accidents and mishaps that lead to some form of physical disability. Moreover, the growing demand for such passive prosthetics in the cosmetics industry is also helping to drive the growth of the market. In recent years, people have become more aware about the treatment techniques and the benefits offered by the passive prosthetics. This has significantly helped in increasing the popularity of the market among the masses. Moreover, the constant developments and advancements in the healthcare sector are also helping the market growth. Both public and private sector investments are helping the passive prosthetics manufacturers to develop new and affordable products that will cater to the wide range of demands across the globe.